Vestal Point Capital »

Biohaven shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $25M 500k 49.97

More positions owned by Vestal Point Capital

Insmed Com Par $.01 (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Inari Medical Ord (NARI)
Arcellx Common Stock (ACLX)
Structure Therapeutics Sponsored Ads (GPCR)
Kalvista Pharmaceuticals (KALV)
Astria Therapeutics (ATXS)
Immatics NV SHS (IMTX)
Ultragenyx Pharmaceutical (RARE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Soleno Therapeutics (SLNO)
Day One Biopharmaceuticals I (DAWN)
Savara (SVRA)
Agios Pharmaceuticals (AGIO)

View all positions for Vestal Point Capital

Top funds holding Biohaven

Vanguard Group
BlackRock
Stifel Financial
Henderson Group
Suvretta Capital Management
Farallon Capital Management
T. Rowe Price Associates
State Street Corporation
RP Management
Bellevue Group
Citadel Advisors
FMR
Geode Capital Management
Point72 Asset Management
Perceptive Advisors

View all funds holding Biohaven